A recent landmark study reveals that over 3 billion people globally are affected by neurological conditions, which have become the leading cause of ill health and disability. Notably, there has been a 76% increase in new clinical trials for neurological disorders from 2015 to 2024, highlighting a growing focus on developing disease-modifying therapies, particularly as the aging population affects these statistics. However, trials face challenges such as slow patient recruitment, subjective assessment endpoints, and the need for study partners, particularly in late-stage neurodegenerative disease trials. The industry is also adapting to a decentralized approach, integrating community-based research to improve access and participation among underrepresented populations.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.clinicaltrialsarena.com/sponsored/bridging-gaps-in-neurology-trials-community-based-research-models/
